AZD4573 is a potent and highly selective CDK9 inhibitor. It affects cell cycle and DNA damage response pathways by triggering transcription-replication conflicts and inducing DNA damage, effectively inhibiting cancer cell proliferation.
AZD4573: Mechanism of Action
AZD4573 MOA：Targeting CDK9/Transcription Elongation Pathway for Hematological Malignancies